Trastuzumab plus docetaxel in metastatic breast cancer

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1432-1433, 2004-01, pp. : 12-12

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Docetaxel/trastuzumab combination therapy for the treatment of breast cancer

By Nabholtz Jean-marc Gligorov Joseph

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 9, 2005-08 ,pp. : 1555-1564

Informa Healthcare

Access to resources Recommend Favorite

Trastuzumab/docetaxel/platinum salts for advanced breast cancer

Inpharma, Vol. 1, Iss. 1442, 2004-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Phase II and Pharmacological Study of Oral Docetaxel Plus Cyclosporin A in Anthracycline Pre-Treated Metastatic Breast Cancer

Current Clinical Pharmacology, Vol. 9, Iss. 2, 2014-05 ,pp. : 139-147

Bentham Science Publishers

Access to resources Recommend Favorite

Optimize Administration Protocol of Capecitabine Plus Docetaxel Combination in Metastatic Breast Cancer Patients

Current Topics in Medicinal Chemistry, Vol. 12, Iss. 15, 2012-08 ,pp. : 1665-1668

Bentham Science Publishers

Access to resources Recommend Favorite

Trastuzumab vs chemotherapy in metastatic breast cancer

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 378, 2002-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite